These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37452084)

  • 1. Identification of appropriate biochemical parameters and cut points to detect Maturity Onset Diabetes of Young (MODY) in Asian Indians in a clinic setting.
    Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
    Sci Rep; 2023 Jul; 13(1):11408. PubMed ID: 37452084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical features and complications of common forms of Maturity Onset Diabetes of the Young (MODY) seen at a tertiary diabetes centre in south India.
    Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
    Prim Care Diabetes; 2023 Aug; 17(4):401-407. PubMed ID: 37055265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA.
    Alemán-Contreras R; Gómez-Díaz RA; Noyola-García ME; Mondragón-González R; Wacher N; Ferreira-Hermosillo A
    Life (Basel); 2024 Apr; 14(5):. PubMed ID: 38792571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.
    Liu J; Xiao X; Zhang Q; Yu M
    J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.
    Warncke K; Kummer S; Raile K; Grulich-Henn J; Woelfle J; Steichen E; Prinz N; Holl RW
    J Clin Endocrinol Metab; 2019 Mar; 104(3):845-855. PubMed ID: 30535056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.
    Ping F; Fu J; Xiao X
    Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Prediction Model to Distinguish Maturity-Onset Diabetes of the Young From Type 1 and Type 2 Diabetes in the Chinese Population.
    Fu J; Ping F; Wang T; Liu Y; Wang X; Yu J; Deng M; Liu J; Zhang Q; Yu M; Li M; Li Y; Xiao X
    Endocr Pract; 2021 Aug; 27(8):776-782. PubMed ID: 33991656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and C-peptide are important for the promptly differential diagnosis of maturity-onset diabetes from familial type 2 diabetes in outpatient clinic.
    Wu HX; Tang J; Li L; Liu SP; Zhou ZG; Yang JX; Yan DW; Zhou HD
    Endocr J; 2019 Apr; 66(4):309-317. PubMed ID: 30760653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes.
    Sampathkumar G; Valiyaparambil PP; Kumar H; Bhavani N; Nair V; Menon U; Menon A; Abraham N; Chapla A; Thomas N
    J Endocrinol Invest; 2022 Mar; 45(3):607-615. PubMed ID: 34741762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).
    Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA
    Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
    Majidi S; Fouts A; Pyle L; Chambers C; Armstrong T; Wang Z; Batish SD; Klingensmith G; Steck AK
    Diabetes Technol Ther; 2018 Feb; 20(2):106-112. PubMed ID: 29355436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children.
    Xu A; Lin Y; Sheng H; Cheng J; Mei H; Ting TH; Zeng C; Liang C; Zhang W; Li C; Li X; Liu L
    Pediatr Diabetes; 2020 May; 21(3):431-440. PubMed ID: 31957151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular background and clinical characteristics of HNF1A MODY in a Polish population.
    Skupien J; Gorczynska-Kosiorz S; Klupa T; Cyganek K; Wanic K; Borowiec M; Sieradzki J; Malecki MT
    Diabetes Metab; 2008 Nov; 34(5):524-8. PubMed ID: 18838325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Predictive Potential of C-Peptide in Differentiating Type 1 Diabetes From Type 2 Diabetes in an Outpatient Population in Abu Dhabi.
    Iqbal S; Jayyab AA; Alrashdi AM; Shujauddin S; Clua-Espuny JL; Reverté-Villarroya S
    Clin Ther; 2024 Sep; 46(9):696-701. PubMed ID: 39117487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms.
    Welsch S; Harvengt A; Gallo P; Martin M; Beckers D; Mouraux T; Seret N; Lebrethon MC; Helaers R; Brouillard P; Vikkula M; Lysy PA
    Diabetes Metab J; 2024 Sep; 48(5):949-959. PubMed ID: 38523249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adiponectin helps to differentiate type 1 and type 2 diabetes among young Asian Indians.
    Gokulakrishnan K; Aravindhan V; Amutha A; Abhijit S; Ranjani H; Anjana RM; Unnikrishnan R; Miranda P; Narayan KM; Mohan V
    Diabetes Technol Ther; 2013 Aug; 15(8):696-702. PubMed ID: 23902401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical screening strategy to distinguish
    Ma Y; Gong S; Wang X; Cai X; Xiao X; Gu W; Yang J; Zhong L; Xiao J; Li M; Liu W; Zhang S; Zhou X; Li Y; Zhou L; Zhu Y; Luo Y; Ren Q; Huang X; Gao X; Zhang X; Zhang R; Chen L; Wang F; Wang Q; Hu M; Han X; Ji L
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32238361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)].
    Datz N; Nestoris C; von Schütz W; Danne T; Driesel AJ; Maringa M; Kordonouri O
    Dtsch Med Wochenschr; 2011 May; 136(21):1111-5. PubMed ID: 21590629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic characteristics of maturity-onset diabetes of the young type 13: A systematic review of the literature.
    Chen Y; Hu X; Zhao M
    J Diabetes; 2024 Mar; 16(3):e13520. PubMed ID: 38095268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.